Call Us: 1.800.873.5297

By

Pradaxa Lawsuit Update (MDL 2385): Recent Articles Raise Issue of Credibility with Company’s own Clinical Trial

The Hamilton Spectator found interest in lawsuits filed in July 2013 by Samuel Richardson of Castlewood, Va. and Billie Jean Benitez of Fair Oaks, Ca. While these are two plaintiffs amongst nearly 2,300 in the pending Multidistrict Litigation, In re: Pradaxa® (Dabigatran Etexilate) Products Liability Litigation (MDL 2385, Case No. 12-md-2385), who have filed cases […]

By

New Research: Testosterone Drugs Linked to Increased Risk of Blood Clots, Heart Attack and Stroke

The FDA recently announced the launch of an investigation of the cardiovascular risks associated with testosterone therapy. The medical safety alert is to warn men of potential risks and/or side effects associated with testosterone therapy. Studies have shown that, as early as one month and up to the first 90 days after starting testosterone therapy, dangerous […]

By

Pradaxa Lawsuit Update (MDL 2385): News Articles Report BI Altered Research Paper it Feared Would Harm Sales

What if a pharmaceutical company knew that its drug required frequent testing to reduce the potential danger to patients, yet hid that information? According to two recent news articles, the manufacturer of the anticoagulant drug Pradaxa may have done just that. The problem may start with “the fact that much of the research on drugs […]

By

Actos® MDL Trial Update (MDL 2299): Judge Rules that Jury Can Hear Claims Over Takeda’s Destroyed Files

Bloomberg reports that The Honorable Judge Rebecca F. Doherty, who presides over the Actos® Multidistrict Litigation (MDL 2299), has decided that Takeda must allow the jury for the first federal trial to hear claims that it intentionally destroyed files related to its Actos® diabetes drug. Officials at the Osaka, Japan-based Takeda admitted they cannot find […]

By

Minnesota Plaintiff Overcomes Federal Preemption in Medtronic Infuse® Case: Judge Rules that Case Allowed to Proceed

The Star Tribune reports that a Minnesota judge has agreed to allow a Medtronic Infuse® bone graft case to proceed. In particular, Judge Laurie Miller will allow a Minnesota man to sue Medtronic over injuries he alleges was caused by Medtronic’s Infuse® bone graft product and to bring three charges of fraud and misrepresentation. The […]

By

FDA Requests Clinical Data from AstraZeneca due to Heart Failure Risk Associated with Type 2 Diabetes Drugs Onglyza® and Kombiglyze XR®

The United States Food and Drug Administration (FDA) has issued a Drug Safety Communication informing doctors and consumers that it has “requested clinical trial data from the manufacturer of saxagliptin to investigate a possible association between use of the type 2 diabetes drug and heart failure.” Saxagliptin is a Type 2 diabetes drug marketed as […]

By

$56 Million Settlement Reached Against Hip Implant Manufacturer Biomet

Law 360 reports that Biomet Inc., the manufacturer of the M2a-38 and M2a-Magnum hip implants, have agreed to a $56 million settlement. This settlement will end the federal lawsuit against the company that was consolidated into a Multidistrict Litigation in 2012. The Multidistrict Litigation is entitled In re: Biomet M2a Magnum Hip Implant Products Liability […]

By

Actos Lawsuit Update: First Actos Trial in the MDL Underway

The first trial in the Multidistrict Litigation In re: Actos® (Pioglitazone) Products Liability Litigation, MDL 2299, is underway and expected to last six weeks. The Actos® Multidistrict Litigation (MDL 2299) is currently pending in the United States District Court for the Western District of Louisiana before The Honorable Judge Rebecca F. Doherty. According to the […]

By

Pradaxa Lawsuit Update (MDL 2385): Internal Company Documents Recently Unsealed in MDL, as Reported by The New York Times

The New York Times reports that numerous documents have been made public in the Pradaxa® Multidistrict Litigation entitled In re: Pradaxa® (Dabigatran Etexilate) Products Liability Litigation (MDL 2385, Case No. 12-md-2385) pending in the United States District Court for the Southern District of Illinois. The New York Times provides: “Many of the documents released by […]

By

NuvaRing Lawsuit Update: $100 Million Settlement Reached Against Merck

On February 7, 2014, United States District Court Judge Rodney W. Sippel approved a $100 Million settlement in the NuvaRing® Multidistrict Litigation In re: NuvaRing® Products Liability Litigation (MDL No. 1964, Case No. 08-md-1964). Schlichter, Bogard & Denton, LLP are leaders in the national Multidistrict Litigation and have been appointed by Judge Sippel to serve […]

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.